Strongbridge Biopharma PLC Debt to Equity Ratio 2016-2021 | SBBP
Current and historical debt to equity ratio values for Strongbridge Biopharma PLC (SBBP) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Strongbridge Biopharma PLC debt/equity for the three months ending June 30, 2021 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2021-06-30 | $0.05B | $0.04B | 1.18 |
| 2021-03-31 | $0.05B | $0.06B | 0.94 |
| 2020-12-31 | $0.06B | $0.07B | 0.85 |
| 2020-09-30 | $0.04B | $0.08B | 0.58 |
| 2020-06-30 | $0.05B | $0.05B | 1.04 |
| 2020-03-31 | $0.04B | $0.06B | 0.65 |
| 2019-12-31 | $0.05B | $0.07B | 0.63 |
| 2019-09-30 | $0.04B | $0.08B | 0.54 |
| 2019-06-30 | $0.04B | $0.09B | 0.48 |
| 2019-03-31 | $0.06B | $0.10B | 0.58 |
| 2018-12-31 | $0.06B | $0.11B | 0.51 |
| 2018-09-30 | $0.15B | $-0.01B | -23.51 |
| 2018-06-30 | $0.15B | $0.01B | 16.63 |
| 2018-03-31 | $0.16B | $0.00B | 87.25 |
| 2017-12-31 | $0.12B | $-0.01B | -9.72 |
| 2017-09-30 | $0.11B | $-0.02B | -5.69 |
| 2017-06-30 | $0.09B | $0.01B | 9.55 |
| 2017-03-31 | $0.08B | $0.04B | 2.05 |
| 2016-12-31 | $0.07B | $0.07B | 1.05 |
| 2016-09-30 | $0.00B | $0.06B | 0.07 |
| 2016-06-30 | $0.01B | $0.07B | 0.07 |
| 2016-03-31 | $0.01B | $0.08B | 0.09 |
| 2015-12-31 | $0.01B | $0.09B | 0.07 |
| 2015-09-30 | $0.00B | 0.00 | |
| 2015-06-30 | $0.00B | 0.00 | |
| 2015-03-31 | $0.00B | 0.00 | |
